Bipartisan Letter to USTR Says China's Medical Device Purchasing Threatens US Industry
Sen. Todd Young, R-Ind., and Sen. Tom Carper, D-Del., told U.S. Trade Representative Katherine Tai that she should talk to Chinese officials about that country's decision to buy medical devices based on the lowest price. The two sent a letter…
Sign up for a free preview to unlock the rest of this article
Timely, relevant coverage of court proceedings and agency rulings involving tariffs, classification, valuation, origin and antidumping and countervailing duties. Each day, Trade Law Daily subscribers receive a daily headline email, in-depth PDF edition and access to all relevant documents via our trade law source document library and website.
Oct. 26 that said before the volume-based procurement rules came into effect, the U.S. exported $6 billion annually in medical devices to China and imported not much more from China in that category. "The medical device industry employs over 400,000 Americans and pays on average 28% higher wages than other manufacturing jobs. Given the importance of this industry to our country’s economy, we must pursue policies that hold China accountable for deliberate actions that harm our job creators and employees. China keeping the current structure of the VBP in place will have ripple effects in communities supported heavily by the medical device industry and could jeopardize access to life-saving products made through cutting-edge technologies," they said.